Secukinumab use in the treatment of Netherton's syndrome.
Christian GanEmma KingDavid OrchardPublished in: The Australasian journal of dermatology (2022)
Netherton syndrome is a rare, severe genetic disorder of cornification without specific treatment. We describe two cases who demonstrated marked cutaneous improvement with secukinumab and suggest a role for IL-17 therapy in treating this condition.